1118
In this report, one patient who developed gangrene after bleomycin and vincristine/vinblastine chemotherapy for AIDS-related Kaposi's sarcoma and another HIV-infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
 ( adverse event: developed ,  one patient: Subject, one: Subject.Population, gangrene: Effect, bleomycin and vincristine/vinblastine: Treatment, bleomycin: Treatment.Drug, vincristine: Treatment.Drug, vinblastine: Treatment.Drug, bleomycin: Combination.Drug, vincristine: Combination.Drug, vinblastine: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  one patient: Subject, one: Subject.Population, gangrene: Effect, bleomycin and vincristine/vinblastine: Treatment, bleomycin: Treatment.Drug, vincristine: Treatment.Drug, vinblastine: Treatment.Drug, bleomycin: Combination.Drug, vincristine: Combination.Drug, vinblastine: Combination.Drug) 